Agenda – 2020

23rd Annual MAD-ID Meeting
May 27-30, 2020

NOTE:  “AASP” denotes an Advanced Antimicrobial Stewardship Program session (entire program constitutes 18 hours CPE [1.8 CEU] and 18 hours CME (AMA PRA Category 1 Credit(s)™)

Wednesday, May 27, 2020
12:00 pm - 7:00 pmRegistration
2:00 pm - 3:30 pmTrainee Pre-Meeting Program
Give Me the Good News First: Transitioning into Infectious Diseases Practice; Erin McCreary, PharmD and Jordan Smith, PharmD
4:00 pm - 6:00 pmClassrooms #1-4 (attend two of the four offered)
Effective use of EMR Programming to Implement Antibiotic Guidelines/pathways (AASP); David Ha, PharmD; Stewardship Classroom #1 (repeated)
Activity Type: Application
ACPE Program: 0485-0000-20-001-L04-P (1.0 Contact Hour)
Learning Objectives:
1. Discuss best practices of electronic medical record design to improve compliance with clinical guidelines
2. List tools within electronic medical records that can be used in implementing or monitoring antimicrobial stewardship strategies
3. Given a clinical problem, design a potential solution utilizing electronic medical record technologies
Dose Optimization of Beta-lactams (AASP); Charles Peloquin, PharmD; Stewardship Classroom #2
Activity Type: Application
ACPE Program: 0485-0000-20-002-L01-P (1.0 Contact Hour)
Learning Objectives:
1. Describe the key pharmacokinetic/pharmacodynamic parameters that optimize beta-lactam antibiotics
2. Compare beta-lactams that are good candidates for dose optimization strategies
3. Demonstrate examples of successful beta-lactam optimization programs that have improved patient outcomes
Supporting ID/ASP Professionals: Preventing Burnout in an Era of Doing More with Less (AASP); Erin McCreary, PharmD; Stewardship Classroom #3 (repeated)
Activity Type: Application
ACPE Program: 0485-0000-20-003-L04-P (1.0 Contact Hour)
Learning Objectives:
1. Describe the prevalence and consequences of burnout in healthcare professions in the context of infectious diseases workforce
2. Compare the typical causes of burnout in individuals and analyze the systemic contributing factors
3. Demonstrate prevention strategies for mitigating burnout
Developing and Using your Antibiogram; John Bosso, PharmD; Stewardship Classroom #4 (repeated)
Activity Type: Application
ACPE Program: 0485-0000-20-004-L01-P (1.0 Contact Hour)
Learning Objectives:
1. State/list the basic requirements for assembly and dissemination of an antibiogram as suggested by CLSI
2. Summarize the susceptibility data that should and should not be included in an antibiogram
3. Explain how one could assemble a combination antibiogram and it application to clinical decision making
6:30 pm - 8:00 pmOpening Reception
Thursday, May 28, 2020
6:30 am – 6:30 pmRegistration/Hospitality Desk
7:00 am - 8:00 amContinental Breakfast In Exhibit Area
8:00 am – 10:00 amClassrooms #5-8 (attend two of the four offered)
Antimicrobial Stewardship in Challenging Environments (AASP); Eddie Stenehjem, MD; Stewardship Classroom #5 (repeated)
Activity Type: Application
ACPE Program: 0485-0000-20-005-L04-P (1.0 Contact Hour)
Learning Objectives:
1. Outline challenges to implementing antimicrobial stewardship in various healthcare settings (e.g. rural, small hospital, telehealth)
2. Identify creative approaches to improving access to antimicrobial stewardship expertise
3. Give an example of how a healthcare network can be used to facilitate antibiotic stewardship in a challenging setting
How to Interpret and Apply Data from in vitro Studies to Patient Care (AASP); Jordon Smith, PharmD; Stewardship Classroom #6. (repeated)
Activity Type: Application
ACPE Program: 0485-0000-20-006-L01-P (1.0 Contact Hour)
Learning Objectives:
1. Describe the types of in vitro susceptibility and pharmacodynamic data that are available in the literature
2. List the pros and cons for using this data for clinical translation
3. Given a clinical situation, explain how this data could be useful for specific antibiotic therapy
How to Win Friends and Influence Outpatient Antibiotic Use; Lisa Dumkow, PharmD; Stewardship Classroom #7 (repeated)
Activity Type: Application
ACPE Program: 0485-0000-20-007 -L04-P (1.0 Contact Hour)
Learning Objectives:
1. State two or more rationales for expansion of an antimicrobial stewardship program into the outpatient arena
2. List two or more parties delivering care in the outpatient environment who would be natural partners for stewardship efforts
3. Propose and defend at least two stewardship initiatives that are likely to affect appropriateness of antimicrobial use and/or safety in the outpatient environment
Tales from the Trenches: Difficult Stewardship Challenges from our Community; Susan Davis, PharmD (facilitator); Stewardship Classroom #8 (repeated)
Activity Type: Application
ACPE Program: 0485-0000-20-008-L01-P (1.0 Contact Hour)
Learning Objectives:
1. Compare strategies for implementing new antibiotics in the management of patients with MDR Gram-negative infections
2. Outline a systematic approach for recommending optimal therapy in patients with C. difficile infection
3. Explain how provider-level antibiotic use data can be used to improve de-escalation of broad spectrum antibiotics
10:00 am – 10:30 amBreak in Exhibit Area
10:30 am – 10:45 amWelcome and Opening Remarks
10:45 am – 11:45 amKeynote: Evolution of PK/PD: Impact on Contemporary Therapeutics, George Drusano, MD
ACPE Program: 0485-0000-20-009 -L01-P (1.0 Contact Hour)
Activity Type: Knowledge
Learning Objectives:
1. Describe the origins of the application of PK/PD principles
2. List the most important PK/PD parameters for adjusting and optimizing antibiotic therapy
3. List some of the current and future challenges for the application of PK/PD methods to patient care
11:45 am - 1:30 pmLunch Break
1:30 pm – 3:00 pmCombination Therapy for Serious Infections (AASP)
ACPE Program: 0485-0000-20-010-L01-P (1.5 Contact Hours)
Activity Type: Knowledge
Topic 1: Combination Therapy for Serious Infections: Staphylococcus aureus; George Sakoulas, MD
Learning Objectives:
1. Describe the clinical challenges of treating serious S. aureus infections
2. Explain the rationale for the use of combination therapy and the controversies surrounding treatment
3. Recommend potential patient scenarios where combination therapy would be most beneficial
Topic 2: Combination Therapy for Serious Infections: Gram-negative Infectious; Ryan Shields, PharmD, MS
Learning Objectives:
1. Discuss the challenges associated with the treatment of gram-negative pathogens
2. Describe the in vitro and animal data that support combination therapy for gram-negative pathogens
3. Discuss the controversies and potential studies needed to support the use of combination therapy
3:00 pm - 3:30 pmBreak in Exhibit Area
3:30 pm - 5:00 pmSepsis 2020 (AASP)
ACPE Program: 0485-0000-20-011-L01-P (1.5 Contact Hours)
Activity Type: Knowledge
Topic 1: Sepsis from the Infectious Disease Perspective; Edward Septimus, MD
Learning Objectives:
1. Recommend guidelines and protocols to improve diagnosis and antibiotic therapy for sepsis
2. Explain the evolving incidence and epidemiology of sepsis
3. Identify best practices for antimicrobial stewardship in sepsis
Topic 2: Sepsis from the Patient Perspective; Mary Millard, MEd
Learning Objectives:
1. Explain how patient advocacy can influence clinical practice in the management of sepsis
2. Describe challenges in communication between healthcare providers and patients with sepsis and their caregivers
3. List strategies to empower patients in decision-making regarding infections and antimicrobial use
5:00 pm – 6:30 pmScientific Poster Session / Wine Reception in Exhibit Area
Friday, May 29, 2020
6:30 am - 6:00 pmHospitality Desk Open
7:00 am – 8:00 amContinental Breakfast In Exhibit Area
8:00 am – 9:30 amA Public Health Crisis: Vaccines (AASP;BCIDP)
ACPE Program0485-0000-20-012-L01-P (1.5 Contact Hours)
Activity Type: Knowledge
Topic 1: Advances in Vaccines; Jeffrey Goad, PharmD, MPH
Learning Objectives:
1. List newer vaccines and explain the importance/clinical relevance of their introduction
2. List recently updated/improved vaccine products and explain the importance/clinical relevance of those changes
3. Describe recent changes in ACIP guidelines and explain the rationale for those changes
Topic 2: Vaccine Mythbusters; Daniel Solomon, MD
Learning Objectives:
1. List two or more common myths regarding standard immunizations (as recommended by ACIP)
2. Describe the sources of information antivaxers cite to justify their beliefs
3. Propose two or more arguments that might be effective in convincing doubtful patients to accept standard vaccinations
9:30 am - 10:00 amBreak in Exhibit Area
10:00 am – 11:30 amAntimicrobial Stewardship in Special Populations (AASP)
ACPE Program: 0485-0000-20-013-L01-P (1.5 Contact Hours)
Activity Type: Knowledge
Topic 1: Pediatrics; Tracy Zembles, PharmD
Learning Objectives:
1. List differences in pediatric infectious disease epidemiology or management that call for differences in stewardship initiatives
2. Describe two or more stewardship initiatives that have proven effective in the pediatric inpatient environment
3. Describe two or more stewardship initiatives that have proven effective in the pediatric outpatient environment
Topic 2: Adults with Cystic Fibrosis; Wendy Bullington, PharmD
Learning Objectives:
1. List opportunities for impactful stewardship initiatives in the cystic fibrosis population
2. Describe successful stewardship interventions that have a proven effect in adult cystic fibrosis patients
3. Justify use of healthcare personnel for stewardship activities in inpatient and/or outpatient cystic fibrosis care programs
11:45 am – 1:30 pmLunch Break
1:30 pm – 3:00 pmA New Era in HIV Management
ACPE Program: 0485-0000-20-014-L01-P (1.5 Contact Hours)
Activity Type: Knowledge
Topic 1: New Therapies, New Problems; Daniel Solomon, MD
Learning Objectives:
1. Describe recent trends in the epidemiology of HIV
2. Discuss strengths and limitations of new treatments for HIV
3. Identify factors that can complicate choice of antiretroviral therapy for patients with HIV
Topic 2: Real Life Challenges in HIV Therapy; Melissa Badowski, PharmD, MPH
Learning Objectives:
1. Evaluate the impact of generic antiretrovirals on management of HIV in the United States
2. Outline approaches for improving access to care for patients with HIV or at high risk
3. Given a patient case, identify safety considerations important in the selection and monitoring of antiretroviral therapy
3:00 pm - 3:30 pmBreak in Exhibit Area
3:30 pm – 5:00 pmDisease State Guidelines Update (AASP;BCIDP)
ACPE Program: 0485-0000-20-015- L01-P (1.5 Contact Hours)
Activity Type: Knowledge
Topic 1: Asymptomatic Bacteriuria; Emily Spivak, MD, MHS
Learning Objectives:
1. Describe the conditions and patient populations for asymptomatic bacteriuria
2. Discuss the issues and drawbacks to treating asymptomatic bacteriuria
3. List the instances where asymptomatic bacteriuria should be treated
Topic 2: Community-acquired Pneumonia; Thomas File, MD
Learning Objectives:
1. Describe the overall management issues surrounding the treatment of CAP
2. Review the major changes in the CAP treatment guidelines
3. Discuss controversies that still remain to be answered regarding the treatment of CAP
5:00 pm - 6:00 pmExhibitor's Reception
Saturday, May 30, 2020
6:30 am - 5:00 pmHospitality Desk Open
7:00 am – 8:00 amContinental Breakfast
8:00 am – 9:30 amEmerging and Difficult to Treat Infections (AASP;BCIDP)
ACPE Program: 0485-0000-20-016-L01-P (1.5 Contact Hours)
Activity Type: Knowledge
Topic 1: Candida auris; Jeffrey Rybak, PharmD, PhD
Learning Objectives:
1. Describe the pharmacological and clinical consequences of antifungal resistance in Candida species
2. Identify epidemiological features associated with Candida auris
3. List infection control and treatment strategies suggested for suspected or known Candida auris
Topic 2: Non-tuberculosis Mycobacteria; Wendy Bullington, PharmD
Learning Objectives:
1. Explain the microbiology and epidemiology of nontuberculous mycobacterial lung disease (NTM-LD)
2. Outline major recommendations in diagnosis and monitoring of NTM-LD
3. Given a clinical scenario, describe how to implement evidence-based treatment recommendations for NTM-LD
9:30 am – 10:00 amBreak
10:00 am – 11:30 amHot Topics: What did you miss at the other ID Meetings?
ACPE Program: 0485-0000-20-017-L01-P (1.5 Contact Hours)
Activity Type: Knowledge
Topic 1: What did you miss at the other ID Meetings (Part 1)? Ryan Shields, PharmD, MS
Learning Objectives:
1. Summarize the ID Hot topics from the major ID meetings
2. Discuss the major controversies highlighted at these meetings
3. List the winners and losers for therapeutic advances from this year in ID pharmacotherapy
Topic 2: What did you miss at the other ID Meetings? (Part 2), Erin McCreary, PharmD
Learning Objectives:
1. Summarize the ID Hot topics from the major ID meetings
2. Discuss the major controversies highlighted at these meetings
3. List the winners and losers for therapeutic advances from this year in ID pharmacotherapy
11:30 am - 12:30 pmMeet the Professors
ACPE Program: 0485-0000-20-018-L01-P (1.0 Contact Hour)
Activity Type: Knowledge
Learning Objectives:
1. Summarize the new principles related to antimicrobial stewardship presented at this meeting
2. Hypothesize and /or explain how to implement these strategies for effective stewardship interventions at their own institution
3. Provide examples of how new information and concepts presented at this meeting will affect patient care in your practice setting
12:30 pmMeeting Adjourns